MCA concludes successful visit to Canada and United States

Chief Executive Officer Dr Jerrol Thompson and Chief Inspector Terral Mapp of the Medicinal Cannabis Authority (MCA), have concluded a successful regulatory assessment visit to Canada and the United States.

The main purpose of their visit was to meet with Ample Organics, a Canadian Seed-to-Sale (Track and Trace) Software company that provides 70% of the Track and Trace services in Canada. Seed-to-Sale systems are used to track the logistics and use of cannabis from its cultivation, processing, patient use and export. They provide a means to identify diversions of cannabis into the illegal market, the unusual patterns of patient use and the financial compliance associated with its use.

As a consequence of this visit, Ample will provide the MCA with a draft proposal to review and sign in order to commence the process between them. Ample will also provide a Patient Access Database software for the MCA-Patient Access system.

The MCA has dedicated a section of its Standard and Compliance Regulations to Track and Trace, considered to be a critical aspect of regulatory compliance.

The MCA CEO and Chief Inspector also visited 15 other entities including a processing facility, laboratory, green- house, outdoor grow facility, dispensary and the New York Department of Health.

While on their visits the MCA team was supported by SVG Ambassador to the United States, Ambassador Lou-anne Gilchrist, Counsel General Ambassador to Canada Fitz Huggins, Bernadette Ambrose Black of the New York Consulate and former Director of the Information Technology Services Division Andre Bailey.